神经细胞培养研究脊髓损伤

Q3 Pharmacology, Toxicology and Pharmaceutics Drug Discovery Today: Disease Models Pub Date : 2017-12-01 DOI:10.1016/j.ddmod.2018.10.005
George A. McCanney, Michael J. Whitehead, Michael A. McGrath, Susan L. Lindsay, Susan C. Barnett
{"title":"神经细胞培养研究脊髓损伤","authors":"George A. McCanney,&nbsp;Michael J. Whitehead,&nbsp;Michael A. McGrath,&nbsp;Susan L. Lindsay,&nbsp;Susan C. Barnett","doi":"10.1016/j.ddmod.2018.10.005","DOIUrl":null,"url":null,"abstract":"<div><p>There are great challenges involved in identifying potential therapies for the repair of spinal cord injury (SCI). It is well accepted that not one, but a combination of therapeutic strategies will be required to effectively repair the damage. However, identifying novel therapeutics is hindered by the lack of reliable methods available that facilitate high throughput screening of numerous compounds. While the use of animals provides an important means for testing new therapies, <em>in vivo</em> models of SCI can be time consuming and require the use of large cohorts of animals. In this review, we have focused on three aspects of repair following SCI (1) neurite outgrowth, (2) glial scar and (3) remyelination. No <em>in vitro</em> model encapsulates all the features of SCI and we discuss the limitations and virtues of the various cultures, which range from individual cell-types through to complex co-cultures. We discuss how these cultures can be used as a moderate throughput screen to identify novel therapeutics for CNS repair before being verified in animal models.</p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.10.005","citationCount":"4","resultStr":"{\"title\":\"Neural cell cultures to study spinal cord injury\",\"authors\":\"George A. McCanney,&nbsp;Michael J. Whitehead,&nbsp;Michael A. McGrath,&nbsp;Susan L. Lindsay,&nbsp;Susan C. Barnett\",\"doi\":\"10.1016/j.ddmod.2018.10.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>There are great challenges involved in identifying potential therapies for the repair of spinal cord injury (SCI). It is well accepted that not one, but a combination of therapeutic strategies will be required to effectively repair the damage. However, identifying novel therapeutics is hindered by the lack of reliable methods available that facilitate high throughput screening of numerous compounds. While the use of animals provides an important means for testing new therapies, <em>in vivo</em> models of SCI can be time consuming and require the use of large cohorts of animals. In this review, we have focused on three aspects of repair following SCI (1) neurite outgrowth, (2) glial scar and (3) remyelination. No <em>in vitro</em> model encapsulates all the features of SCI and we discuss the limitations and virtues of the various cultures, which range from individual cell-types through to complex co-cultures. We discuss how these cultures can be used as a moderate throughput screen to identify novel therapeutics for CNS repair before being verified in animal models.</p></div>\",\"PeriodicalId\":39774,\"journal\":{\"name\":\"Drug Discovery Today: Disease Models\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.10.005\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today: Disease Models\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1740675718300161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675718300161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 4

摘要

寻找脊髓损伤(SCI)修复的潜在治疗方法是一个巨大的挑战。人们普遍认为,要有效地修复损伤,需要的不是一种治疗策略,而是多种治疗策略的结合。然而,由于缺乏可靠的方法来促进对许多化合物的高通量筛选,鉴定新的治疗方法受到阻碍。虽然使用动物为测试新疗法提供了重要手段,但脊髓损伤的体内模型可能是耗时的,并且需要使用大量动物。在这篇综述中,我们主要从三个方面探讨脊髓损伤后的修复(1)神经突生长,(2)神经胶质瘢痕和(3)髓鞘再生。没有一个体外模型囊括了SCI的所有特征,我们讨论了各种培养的局限性和优点,范围从单个细胞类型到复杂的共培养。我们讨论了在动物模型验证之前,如何将这些培养物用作中等通量筛选,以确定用于中枢神经系统修复的新疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Neural cell cultures to study spinal cord injury

There are great challenges involved in identifying potential therapies for the repair of spinal cord injury (SCI). It is well accepted that not one, but a combination of therapeutic strategies will be required to effectively repair the damage. However, identifying novel therapeutics is hindered by the lack of reliable methods available that facilitate high throughput screening of numerous compounds. While the use of animals provides an important means for testing new therapies, in vivo models of SCI can be time consuming and require the use of large cohorts of animals. In this review, we have focused on three aspects of repair following SCI (1) neurite outgrowth, (2) glial scar and (3) remyelination. No in vitro model encapsulates all the features of SCI and we discuss the limitations and virtues of the various cultures, which range from individual cell-types through to complex co-cultures. We discuss how these cultures can be used as a moderate throughput screen to identify novel therapeutics for CNS repair before being verified in animal models.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
期刊最新文献
Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health Women’s reproductive system as balanced estradiol and progesterone actions—A revolutionary, paradigm-shifting concept in women’s health Influence of progestagens on bone health. Bone changes related to ovulatory disturbances and low progesterone levels Hereditary bullous diseases: current and innovative models to study the skin blistering disease epidermolysis bullosa The extent and causes of natural variation in menstrual cycles: Integrating empirically-based models of ovarian cycling into research on women’s health
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1